search
Back to results

Clinical Performance of Stenfilcon A Versus Filcon II 3

Primary Purpose

Myopia

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
stenfilcon A
filcon II 3
Sponsored by
Coopervision, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Myopia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Subjects must satisfy the following conditions prior to inclusion in the study:

  • Based on his/her knowledge, must be in good general health. Be of legal age (18 years) or older.
  • Be able and willing to adhere to the instructions set forth in this protocol and complete all specified evaluation.
  • Read, indicate understanding of, and sign Written Informed Consent (Appendix 1)
  • Require a contact lens prescription between -0.50 and -6.00 and have no more than -.75dioptor (D) of astigmatism in both eyes
  • Achieve visual acuity of 6/9 or better in each eye with a spherical contact lens prescription.
  • An existing soft contact lens wearer of any modality.
  • Must be able to wear their lenses at least 6 full days over the 7 days; 14 hours per day, assuming there are no contraindications for doing so.
  • Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:
  • No amblyopia.
  • No evidence of lid abnormality or infection (e.g. entropion, ectropion, chalazia, recurrent styes).
  • No clinically significant slit lamp findings (e.g. infiltrates or other slit lamp findings greater than Grade 2: corneal edema, tarsal abnormalities, and conjunctival injection).
  • No other active ocular disease (e.g. glaucoma, history of recurrent corneal erosions, cornea [infiltrates], conjunctiva, lids, and intraocular infection or inflammation of an allergic, bacterial, or viral etiology.)
  • No aphakia

Exclusion Criteria:

Any of the following will render a subject ineligible for inclusion:

  • Neophytes, who have not worn lenses before
  • Greater than 0.75D of refractive astigmatism in either eye
  • Presence of clinically significant (grade 3 or above) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
  • Presence of ocular or systemic disease or need of medication which might interfere with contact lens wear.
  • Slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Pterygium, pinguecula or corneal scars within the visual axis
  • Neovascularization > 0.75 mm in from the limbus
  • Giant papillary conjunctivitis (GPC) Grade 3 or above
  • Anterior uveitis or iritis (past or present)
  • Seborrheic eczema, seborrheic conjunctivitis
  • History of corneal ulcer or fungal infections
  • Poor personal hygiene
  • A known history of corneal hypoesthesia (reduced corneal sensitivity).
  • Contact lens best corrected Snellen visual acuities (VA) worse than 6/9
  • Aphakia, Keratoconus or a highly irregular cornea

Sites / Locations

  • University of Aston

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

stenfilcon A

filcon II 3

Arm Description

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Outcomes

Primary Outcome Measures

Daily and Comfortable Wearing Time
Participant rating of lens Daily and Comfortable Wearing Time. Collected at baseline for all habitual lenses.(The hours of average comfortable wearing time and average daily wearing time.)
Daily and Comfortable Wearing Time
Participant rating of lens Daily and Comfortable Wearing Time. Collected at 1 week wear for each lens.(The hours of average comfortable wearing time and average daily wearing time.)
Handling
Participant rating for lens handling. Collected at 1 week. (Insertion: 0-100, 0= could not get it in and 100= went in without a problem. Removal: 0= could not get it out and 100= came out without a problem. Blister: 0=impossible and 100=came out extremely easily).
Comfort
Participant rating of lens comfort. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable,100=extreme comfort / cannot feel them at all)
Comfort
Participant rating for comfort. Collected at 1 week. (0-100, 0= very uncomfortable and 100= extreme comfort/cannot feel them at all).
Dryness
Participant rating of lens dryness. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable, 100=extreme comfort/ cannot feel them at all)
Dryness
Participant rating for dryness. Collected at 1 week. (0-100, 0= very uncomfortable and 100= extreme comfort/cannot feel them at all).
Vision Quality
Participant rating of vision quality. Collected at baseline for habitual lens. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)
Vision Quality
Participant rating of vision quality. Collected at 1 week. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)
Eye Whiteness
Participant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).
Eye Whiteness
Participant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).
Overall Satisfaction
Participant rating for overall satisfaction. Collected at baseline for habitual lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).
Overall Satisfaction
Participant rating for overall satisfaction. Collected at 1 week for study lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).
Visual Acuity logMAR
Assessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at baseline for habitual lens. logMAR.
Visual Acuity logMAR
Assessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at dispense for study lenses. logMAR.
Visual Acuity logMAR
Assessment of Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at 1 week for study lenses. logMAR
Wettability
Participant rating for surface wettability. Collected at 1 week. Tear film analysis in seconds.

Secondary Outcome Measures

Blood Vessel Coverage
Assessment of ocular health. Collected at baseline after removal of lenses. Percent of blood vessel coverage.
Blood Vessel Coverage
Assessment of ocular health. Collected at 1 week after removal of lenses. Percentage of blood vessel coverage.
Conjunctival Redness
Assessment of ocular health. Collected at baseline after removal of lenses. Percentage of conjunctival redness.
Conjunctival Redness
Assessment of ocular health. Collected at 1 week after removal of lenses. Percentage of conjunctival redness.
Corneal Staining
Assessment of ocular health. Collected at baseline after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )
Corneal Staining
Assessment of ocular health. Collected at 1 week after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )
Conjunctival Staining
Assessment of ocular health. Collected at 1 week after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )

Full Information

First Posted
February 14, 2013
Last Updated
July 19, 2020
Sponsor
Coopervision, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT01808209
Brief Title
Clinical Performance of Stenfilcon A Versus Filcon II 3
Official Title
Clinical Performance of Stenfilcon A Versus Filcon II 3
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
January 2013 (undefined)
Primary Completion Date
April 2013 (Actual)
Study Completion Date
May 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coopervision, Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Clinical Performance of Stenfilcon vs. Filcon II 3
Detailed Description
The objective of this study is to compare the comfort and clinical performance of Stenfilcon vs. Filcon II 3 compared to subject's habitual contact lenses. The null hypothesis is that there is no difference in the clinical performance between the two sets of lenses.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
stenfilcon A
Arm Type
Experimental
Arm Description
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
Arm Title
filcon II 3
Arm Type
Active Comparator
Arm Description
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
Intervention Type
Device
Intervention Name(s)
stenfilcon A
Other Intervention Name(s)
stenfilcon A (Daily Disposable Contact Lens)
Intervention Description
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
Intervention Type
Device
Intervention Name(s)
filcon II 3
Other Intervention Name(s)
filcon II 3 (Daily Disposable Contact Lens)
Intervention Description
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
Primary Outcome Measure Information:
Title
Daily and Comfortable Wearing Time
Description
Participant rating of lens Daily and Comfortable Wearing Time. Collected at baseline for all habitual lenses.(The hours of average comfortable wearing time and average daily wearing time.)
Time Frame
Baseline
Title
Daily and Comfortable Wearing Time
Description
Participant rating of lens Daily and Comfortable Wearing Time. Collected at 1 week wear for each lens.(The hours of average comfortable wearing time and average daily wearing time.)
Time Frame
1 week
Title
Handling
Description
Participant rating for lens handling. Collected at 1 week. (Insertion: 0-100, 0= could not get it in and 100= went in without a problem. Removal: 0= could not get it out and 100= came out without a problem. Blister: 0=impossible and 100=came out extremely easily).
Time Frame
1 Week
Title
Comfort
Description
Participant rating of lens comfort. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable,100=extreme comfort / cannot feel them at all)
Time Frame
Baseline
Title
Comfort
Description
Participant rating for comfort. Collected at 1 week. (0-100, 0= very uncomfortable and 100= extreme comfort/cannot feel them at all).
Time Frame
1 Week
Title
Dryness
Description
Participant rating of lens dryness. Collected at baseline for habitual pair. (0-100; 0=very uncomfortable, 100=extreme comfort/ cannot feel them at all)
Time Frame
Baseline
Title
Dryness
Description
Participant rating for dryness. Collected at 1 week. (0-100, 0= very uncomfortable and 100= extreme comfort/cannot feel them at all).
Time Frame
1 Week
Title
Vision Quality
Description
Participant rating of vision quality. Collected at baseline for habitual lens. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)
Time Frame
Baseline
Title
Vision Quality
Description
Participant rating of vision quality. Collected at 1 week. (0-100; 0=extremely poor vision totally blurred 100=excellent vision totally sharp)
Time Frame
1 Week
Title
Eye Whiteness
Description
Participant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).
Time Frame
Baseline
Title
Eye Whiteness
Description
Participant rating for eye whiteness. Collected at baseline for habitual lenses. (0-100, 0= total redness and 100= totally white).
Time Frame
1 Week
Title
Overall Satisfaction
Description
Participant rating for overall satisfaction. Collected at baseline for habitual lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).
Time Frame
Baseline
Title
Overall Satisfaction
Description
Participant rating for overall satisfaction. Collected at 1 week for study lenses. (0-100, 0= extremely dissatisfied and 100= extremely satisfied).
Time Frame
1 Week
Title
Visual Acuity logMAR
Description
Assessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at baseline for habitual lens. logMAR.
Time Frame
Baseline
Title
Visual Acuity logMAR
Description
Assessment of Monocular (MHCVA) Right eye (OD), left eye (OS) and Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at dispense for study lenses. logMAR.
Time Frame
Dispense
Title
Visual Acuity logMAR
Description
Assessment of Binocular High Contrast Distance Visual Acuity (BHCVA). Collected at 1 week for study lenses. logMAR
Time Frame
1 Week
Title
Wettability
Description
Participant rating for surface wettability. Collected at 1 week. Tear film analysis in seconds.
Time Frame
1 Week
Secondary Outcome Measure Information:
Title
Blood Vessel Coverage
Description
Assessment of ocular health. Collected at baseline after removal of lenses. Percent of blood vessel coverage.
Time Frame
Baseline
Title
Blood Vessel Coverage
Description
Assessment of ocular health. Collected at 1 week after removal of lenses. Percentage of blood vessel coverage.
Time Frame
1 Week
Title
Conjunctival Redness
Description
Assessment of ocular health. Collected at baseline after removal of lenses. Percentage of conjunctival redness.
Time Frame
Baseline
Title
Conjunctival Redness
Description
Assessment of ocular health. Collected at 1 week after removal of lenses. Percentage of conjunctival redness.
Time Frame
1 Week
Title
Corneal Staining
Description
Assessment of ocular health. Collected at baseline after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )
Time Frame
Baseline
Title
Corneal Staining
Description
Assessment of ocular health. Collected at 1 week after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )
Time Frame
1 Week
Title
Conjunctival Staining
Description
Assessment of ocular health. Collected at 1 week after removal of lenses. (Biomicroscopy, 0-4, 0=none , 4=severe )
Time Frame
1 Week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects must satisfy the following conditions prior to inclusion in the study: Based on his/her knowledge, must be in good general health. Be of legal age (18 years) or older. Be able and willing to adhere to the instructions set forth in this protocol and complete all specified evaluation. Read, indicate understanding of, and sign Written Informed Consent (Appendix 1) Require a contact lens prescription between -0.50 and -6.00 and have no more than -.75dioptor (D) of astigmatism in both eyes Achieve visual acuity of 6/9 or better in each eye with a spherical contact lens prescription. An existing soft contact lens wearer of any modality. Must be able to wear their lenses at least 6 full days over the 7 days; 14 hours per day, assuming there are no contraindications for doing so. Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: No amblyopia. No evidence of lid abnormality or infection (e.g. entropion, ectropion, chalazia, recurrent styes). No clinically significant slit lamp findings (e.g. infiltrates or other slit lamp findings greater than Grade 2: corneal edema, tarsal abnormalities, and conjunctival injection). No other active ocular disease (e.g. glaucoma, history of recurrent corneal erosions, cornea [infiltrates], conjunctiva, lids, and intraocular infection or inflammation of an allergic, bacterial, or viral etiology.) No aphakia Exclusion Criteria: Any of the following will render a subject ineligible for inclusion: Neophytes, who have not worn lenses before Greater than 0.75D of refractive astigmatism in either eye Presence of clinically significant (grade 3 or above) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures. Presence of ocular or systemic disease or need of medication which might interfere with contact lens wear. Slit lamp findings that would contraindicate contact lens wear such as: Pathological dry eye or associated findings Pterygium, pinguecula or corneal scars within the visual axis Neovascularization > 0.75 mm in from the limbus Giant papillary conjunctivitis (GPC) Grade 3 or above Anterior uveitis or iritis (past or present) Seborrheic eczema, seborrheic conjunctivitis History of corneal ulcer or fungal infections Poor personal hygiene A known history of corneal hypoesthesia (reduced corneal sensitivity). Contact lens best corrected Snellen visual acuities (VA) worse than 6/9 Aphakia, Keratoconus or a highly irregular cornea
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James Wolffsohn, PhD
Organizational Affiliation
University of Aston Birmingham, West Midlands, United Kingdom
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Aston
City
Birmingham
State/Province
West Midlands
ZIP/Postal Code
B4 7ET
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

Clinical Performance of Stenfilcon A Versus Filcon II 3

We'll reach out to this number within 24 hrs